Navigation Links
EntreMed to Present at The New York Society of Security Analysts Industry Conference
Date:12/5/2007

ROCKVILLE, Md., Dec. 5 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S. Burns, President and Chief Executive Officer, will present a Company overview at the NYSSA 2007 Biotech and Specialty Pharmaceuticals Industry Conference, to be held at the Conference Facilities at the NYSSA, New York, December 11-12, 2007. Mr. Burns' presentation is scheduled for Tuesday, December 11, 2007, at 1:35 p.m. (local time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Mr. Burns' live presentation will be web cast and can be accessed through the Company's web site at http://www.entremed.com. An archive will be available on the web site for approximately 90 days.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. Panzem(R) NCD (2-methoxyestradiol or 2ME2) is currently in multiple Phase 2 clinical trials for cancer. MKC-1, an oral cell-cycle regulator, is in multiple Phase 1 and 2 studies for cancer. ENMD-1198, a novel tubulin-binding agent, is in Phase 1 studies in advanced cancers. Panzem(R) is also in preclinical development for rheumatoid arthritis, and ENMD-2076, a dual-acting Aurora-angiogenesis inhibitor, is in preclinical development for cancer. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammatio
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...andSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareI...nnovatorandprovideroflessinvasive,miniaturizedcirc...entofadvancedheartfailure,todayannouncedthatitissc...PiperJaffrayHealthCareConferenceat8:00amESTonWedne...ewYorkPalaceHotel,December1-2. ,, Alivewebcasto...
(Date:11/24/2009)....24/PRNewswire-Asia/--ChindexInternational,Inc.,("...anproviderofWestern,healthcareproductsandservicesi...Companywillattendthe21stAnnualPiperJaffray,"Unplug...atthe,NewYorkPalaceHotel. , Managementiscurre...er1,2009,andholdone-on-onemeetingsthroughouttheday...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--Endologix,Inc.(Nasdaq:...orticdisorders,announcedtodaythatithasfiledamotion...ingementlawsuitbroughtagainstitinOctober2009byCook...rtinIndianapolis,Indiana. ,, Endologixhasreques...tentandTrademarkOffice(USPTO)conductsproceedingsto...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2China Biologic Products Hosts its First Forum for Strategy and Development 13057 1China Biologic Products Hosts its First Forum for Strategy and Development 13057 2China Biologic Products Hosts its First Forum for Strategy and Development 13057 3Ready 3F AIM 21 Target Success 21 AIM Expands Global Reach Through Innovative Corporate Portal from Web to Enterprise 2 0 51877 1Ready 3F AIM 21 Target Success 21 AIM Expands Global Reach Through Innovative Corporate Portal from Web to Enterprise 2 0 51877 2Oncolytics Biotech 28R 29 Inc Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC 4734 1Oncolytics Biotech 28R 29 Inc Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC 4734 2
...GEFIELD, Conn., Jan. 17 Boehringer Ingelheim,anno...ndmark RE-LY trial to,evaluate the long-term effic...mbin inhibitor dabigatran etexilate for the preven...ith atrial fibrillation. RE-LY (Randomized,Evaluat...gest stroke,prevention in atrial fibrillation tria...
...LO PARK, Calif., Jan. 16 Cogentus Pharmaceuticals...linical study to confirm,the full antiplatelet act...CGT-2168 is a once-daily capsule that combines clo...bb Co. and Sanofi-Aventis as Plavix(R)) with,a gas...testinal safety of,antiplatelet therapy., (Logo: ...
Other Medicine Technology:Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study 2Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study 3Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study 4Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168 2
(Date:11/27/2009)...e,Nov.27/PRNewswire/--TeamGarmin-Slipstream,theeli...lsportinganddevelopingthenextgenerationofcyclingch...ransitionswiththeadditionofTransitionsOpticalasane...adingmanufacturerofadaptiveeyewear,offeringthemost...ofspectaclelensessuchasTransitionslensesaswellasTr...
(Date:11/27/2009)...re/-- Allrecipes.com , theworld,s#1foodsite,recei...han2.8millionvisitorsthedaybeforeThanksgiving,prov...olidayoftheyear.TheaverageThanksgivingmealin2009we...fromlastyear,sfeast.AccordingtotheAllrecipessite, ...givingrecipe,acontrastfromlastyear,spopular Homest...
(Date:11/26/2009)...re/--Withcoldandfluseasonuponus,it,smoreimportantt...fectionsandavoidillness. ,, "Weneedtobeproactiv...ingillnessifwe,resick,"saidEileenFinerty,RN,MS,CIC...nfectioncontrolandoccupationalhealthatHospitalforS...ecialSurgeryhasoneofthelowestinfectionratesofanyho...
(Date:11/26/2009)...n an emotional rollercoaster, study finds , ...t the fear factor meets the jubilant sports fan. ,...ally those who root for the winning team -- enjoy ...ted match and victory was in doubt, producing feel...this Thanksgiving weekend as you,re glued to the T...
(Date:11/26/2009)... & Ennis, P.A. is offering free nationwide con...n birth control pills who have suffered a Deep Vei...art Attack or other related cardiac issues or had ...e at 1-800-856-6405 or go to the firm’s webs...nline case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
... Against the backdrop of growing health concerns a...fats on health, consumers are ratcheting up pressu...merging as ideal substitutes for hydrogenated fats... upward trajectory. , , (Logo: http://www.newsco...
...y research team has found that a painful pelvic af...ently in adolescent boys. Chronic prostatitis or c...tal disease associated with persistent and life-al...ve impact that pain, urinary symptoms, and depress...
...sure, Reduces Procedure Time, Lowers , Costs , , ...of Ottawa Heart Institute (UOHI) has installed No...-ray for clinical use, allowing physicians to more... a similar amount and offers other benefits. , "Th...
...ased today titled Assessing State Firefighter Can...r Research , found there is inadequate scientific ...firefighter and an elevated risk of contracting ca...ble to determine that firefighters face risks grea...
... of 105 post-menopausal vegan Buddhist nuns and 10...sical respect, has produced a surprising result. T...led by Professor Tuan Nguyen from Sydney,s Garvan ...r findings are now published online in Osteoporos...
...ore.com , inc. (Nasdaq: DSCM ), a leading online...products, will announce its financial results for ... Wednesday, April 29, 2009 at 5:00 p.m. ET (2:00 p....investor.drugstore.com . , , (Logo: http://ww...
Other Medicine News:Health News:Innovation and Strategic Alliances Come to the Rescue of Participants in Mature Brazilian Market for Food Emulsifiers, Finds Frost & Sullivan 2Health News:Innovation and Strategic Alliances Come to the Rescue of Participants in Mature Brazilian Market for Food Emulsifiers, Finds Frost & Sullivan 3Health News:Innovation and Strategic Alliances Come to the Rescue of Participants in Mature Brazilian Market for Food Emulsifiers, Finds Frost & Sullivan 4Health News:Pelvic pain as prevalent in teens as older males, Queen's researchers discover 2Health News:University of Ottawa Heart Institute is North America's First Clinical Site for Ultra-sophisticated X-Ray 2Health News:Study Fails to Establish Link Between Cancer and Firefighting 2Health News:Vegan Buddhist nuns have same bone density as non-vegetarians 2Health News:drugstore.com, inc. to Announce First Quarter 2009 Results During Conference Call on Wednesday, April 29, 2009 at 5:00 p.m. ET 2
Avant® 9700
Resolve® Immersion Oil
Immersion Oil, 150 cs
Immersion oil for microscopy
Medicine Products: